COVID-19 with no antibody response in a multiple sclerosis patient treated with cladribine: Implication for vaccination program?

por Gelibter, Stefano, Orrico, Mario, Filippi, Massimo, Moiola, Lucia
Publicado 2021

COVID-19 in cladribine-treated relapsing-remitting multiple sclerosis patients: a monocentric experience

por Preziosa, Paolo, Rocca, Maria A., Nozzolillo, Agostino, Moiola, Lucia, Filippi, Massimo
Publicado 2020

Prognostic factors related to the risk of COVID-19 infection in MS patients

por Montini, Federico, Nozzolillo, Agostino, Moiola, Lucia, Rocca, Maria, Martinelli, Vittorio, Filippi, Massimo
Publicado 2021

Atrioventricular block after fingolimod resumption: a consequence of sphingosine-1-phosphate axis alteration due to COVID-19?

por Orrico, Mario, Nozzolillo, Agostino, Gelibter, Stefano, Sangalli, Francesca, Preziosa, Paolo, Filippi, Massimo, Moiola, Lucia
Publicado 2021

Vaccination Opportunities in Multiple Sclerosis Patients Treated with Cladribine Tablets

por Moiola, Lucia, Riva, Agostino, Nicoletti, Ferdinando, Uccelli, Antonio, Salvetti, Marco, Battistini, Luca, Furlan, Roberto
Publicado 2022

Effectiveness and safety profile of cladribine in an Italian real-life cohort of relapsing–remitting multiple sclerosis patients: a monocentric longitudinal observational study

por Zanetta, Chiara, Rocca, Maria A., Meani, Alessandro, Martinelli, Vittorio, Ferrè, Laura, Moiola, Lucia, Filippi, Massimo
Publicado 2023

Correction to: Effectiveness and safety profile of cladribine in an Italian real-life cohort of relapsing–remitting multiple sclerosis patients: a monocentric longitudinal observat...

por Zanetta, Chiara, Rocca, Maria A., Meani, Alessandro, Martinelli, Vittorio, Ferrè, Laura, Moiola, Lucia, Filippi, Massimo
Publicado 2023

Natalizumab-Related Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis: Findings from an Italian Independent Registry

por Prosperini, Luca, de Rossi, Nicola, Scarpazza, Cristina, Moiola, Lucia, Cosottini, Mirco, Gerevini, Simonetta, Capra, Ruggero
Publicado 2016

Pharmacokinetics and pharmacodynamics of natalizumab in pediatric patients with RRMS

por Ghezzi, Angelo, Comi, Giancarlo, Grimaldi, Luigi Maria, Moiola, Lucia, Pozzilli, Carlo, Fantaccini, Simone, Gallo, Paolo
Publicado 2019

Slowly Expanding Lesions Predict 9-Year Multiple Sclerosis Disease Progression

por Preziosa, Paolo, Pagani, Elisabetta, Meani, Alessandro, Moiola, Lucia, Rodegher, Mariaemma, Filippi, Massimo, Rocca, Maria A.
Publicado 2022

The Communication of Multiple Sclerosis Diagnosis: The Patients' Perspective

por Messina, Maria Josè, Dalla Costa, Gloria, Rodegher, Mariaemma, Moiola, Lucia, Colombo, Bruno, Comi, Giancarlo, Martinelli, Vittorio
Publicado 2015

Changes in cortical motor outputs after a motor relapse of multiple sclerosis

por Chieffo, Raffaella, Straffi, Laura, Inuggi, Alberto, Coppi, Elisabetta, Moiola, Lucia, Martinelli, Vittorio, Comi, Giancarlo, Leocani, Letizia
Publicado 2019

Successful treatment of HIV-associated tumefactive demyelinating lesions with corticosteroids and cyclophosphamide: a case report

por Lazzarin, Serena Marita, Cannizzaro, Miryam, Russo, Tommaso, Sangalli, Francesca, Callea, Marcella, Colombo, Bruno, Moiola, Lucia, Filippi, Massimo
Publicado 2020

In vivo structural and functional assessment of optic nerve damage in neuromyelitis optica spectrum disorders and multiple sclerosis

por Vabanesi, Marco, Pisa, Marco, Guerrieri, Simone, Moiola, Lucia, Radaelli, Marta, Medaglini, Stefania, Martinelli, Vittorio, Comi, Giancarlo, Leocani, Letizia
Publicado 2019

Free Light Chains and Intrathecal B Cells Activity in Multiple Sclerosis: A Prospective Study and Meta-Analysis

por Passerini, Gabriella, Dalla Costa, Gloria, Sangalli, Francesca, Moiola, Lucia, Colombo, Bruno, Locatelli, Massimo, Comi, Giancarlo, Furlan, Roberto, Martinelli, Vittorio
Publicado 2016

Prognostic value of serum neurofilaments in patients with clinically isolated syndromes

por Dalla Costa, Gloria, Martinelli, Vittorio, Sangalli, Francesca, Moiola, Lucia, Colombo, Bruno, Radaelli, Marta, Leocani, Letizia, Furlan, Roberto, Comi, Giancarlo
Publicado 2019

Natalizumab in the pediatric MS population: results of the Italian registry

por Ghezzi, Angelo, Moiola, Lucia, Pozzilli, Carlo, Brescia-Morra, Vincenzo, Gallo, Paolo, Grimaldi, Luigi Maria Edoardo, Filippi, Massimo, G., Giancarlo Comi
Publicado 2015

Divergent Trends of Anti-JCPyV Serum Reactivity and Neutralizing Activity in Multiple Sclerosis (MS) Patients during Treatment with Natalizumab

por Diotti, Roberta Antonia, Capra, Ruggero, Moiola, Lucia, Caputo, Valeria, De Rossi, Nicola, Sangalli, Francesca, Martinelli, Vittorio, Burioni, Roberto, Clementi, Massimo, Mancini, Nicasio
Publicado 2016

Alemtuzumab Use in Clinical Practice: Recommendations from European Multiple Sclerosis Experts

por Berger, Thomas, Elovaara, Irina, Fredrikson, Sten, McGuigan, Chris, Moiola, Lucia, Myhr, Kjell-Morten, Oreja-Guevara, Celia, Stoliarov, Igor, Zettl, Uwe K.
Publicado 2016

Loss of Circulating CD8+ CD161(high) T Cells in Primary Progressive Multiple Sclerosis

por Acquaviva, Massimo, Bassani, Claudia, Sarno, Nicole, Dalla Costa, Gloria, Romeo, Marzia, Sangalli, Francesca, Colombo, Bruno, Moiola, Lucia, Martinelli, Vittorio, Comi, Giancarlo, Farina, Cinthia
Publicado 2019